Quels schémas vaccinaux contre les infections respiratoires chez l’insuffisant cardiaque ?

[1]  D. Morrow,et al.  Epidemiology of Cardiogenic Shock in Hospitalized Adults With COVID-19 : A Report From the American Heart Association COVID-19 Cardiovascular Disease Registry. , 2021, Circulation. Heart failure.

[2]  P. Ponikowski,et al.  COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology , 2021, European journal of heart failure.

[3]  N. Lamblin,et al.  Vaccination for Respiratory Infections in Patients with Heart Failure , 2021, Journal of clinical medicine.

[4]  S. E. Jensen,et al.  Influenza Vaccination After Myocardial Infarction , 2021, Circulation.

[5]  P. Hotez,et al.  Myocarditis With COVID-19 mRNA Vaccines , 2021, Circulation.

[6]  L. Barbieri,et al.  Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship? , 2021, Anatolian journal of cardiology.

[7]  N. Lamblin,et al.  Coronavirus disease vaccination in heart failure: No time to waste , 2021, Archives of Cardiovascular Diseases.

[8]  Akshay S. Desai,et al.  Incidence and Outcomes of Pneumonia in Patients With Heart Failure. , 2021, Journal of the American College of Cardiology.

[9]  S. Solomon,et al.  Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19 , 2020, JACC: Heart Failure.

[10]  Benjamin S. Glicksberg,et al.  Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19 , 2020, Journal of the American College of Cardiology.

[11]  A. Cohen,et al.  Left ventricular ejection fraction: An additional risk marker in COVID-19 , 2020, Archives of Cardiovascular Diseases.

[12]  A. Borobia,et al.  Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications , 2020, European journal of heart failure.

[13]  F. Marra,et al.  The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[14]  G. Duarte,et al.  Pneumococcal vaccination in adults at very-high risk or established cardiovascular disease: systematic review and meta-analysis. , 2020, European heart journal. Quality of care & clinical outcomes.

[15]  C. McCarthy,et al.  Inflammation in Heart Failure: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.

[16]  Allan Schwartz,et al.  COVID-19 and Cardiovascular Disease , 2020, Circulation.

[17]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[18]  S. D. De Meyer,et al.  Neutrophil Extracellular Traps in Arterial and Venous Thrombosis , 2019, Seminars in Thrombosis and Hemostasis.

[19]  S. Solomon,et al.  Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. , 2018, JACC. Heart failure.

[20]  L. Rosella,et al.  Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection , 2018, The New England journal of medicine.

[21]  Adrian F. Hernandez,et al.  Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. , 2017, JACC. Heart failure.

[22]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[23]  Akshay S. Desai,et al.  Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. , 2016, JACC. Heart failure.

[24]  Deepak L. Bhatt,et al.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. , 2013, JAMA.

[25]  W. Abraham,et al.  Venous thromboembolic disease in congestive heart failure. , 2010, Congestive heart failure.

[26]  C. O'connor,et al.  Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. , 2008, Archives of internal medicine.

[27]  J. Hedlund,et al.  Additive preventive effect of influenza and pneumococcal vaccines in elderly persons , 2004, European Respiratory Journal.